PVLA R&D Expenses
Palvella Therapeutics Inc · R&D Expenses
PVLA R&D Expenses
Latest reported$12.47Mperiod ending
PVLA Quarterly R&D Expenses ($12.82M → $12.47M)
Quarterly R&D Expenses
High-resolution chart · PNG
PVLA r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 12,473,000 | |
| 9,334,000 | |
| 7,121,000 | |
| 6,528,000 | |
| 5,118,000 | |
| 4,074,000 | |
| 2,543,000 | |
| 3,196,000 | |
| 1,442,000 | |
| 984,000 | |
| 4,454,000 | |
| 9,595,000 | |
| 13,570,000 | |
| 12,819,000 |